Stopped (vs. unchanged) | Reduced (vs. unchanged) | Increased (vs. unchanged) | ||||
---|---|---|---|---|---|---|
aRRR [IC 95%] | p | aRRR [IC 95%] | p | aRRR [IC 95%] | p | |
Female | 0.71 [0.50, 1.00] | 0.050 | 0.91 [0.74, 1.12] | 0.385 | 1.34 [1.10, 1.62] | 0.003 |
Age group (years) | ||||||
18 to 25 | 0.84 [0.50, 1.41] | 0.512 | 1.61 [1.16, 2.24] | 0.005 | 1.45 [1.07, 1.97] | 0.018 |
26 to 45 | 0.88 [0.55, 1.41] | 0.593 | 1.44 [1.06, 1.95] | 0.021 | 1.39 [1.05, 1.84] | 0.021 |
> 45 | Ref | Ref | Ref | |||
Education level ≥ secondary school diploma | 1.67 [1.11, 2.51] | 0.014 | 1.19 [0.94, 1.50] | 0.155 | 1.29 [1.03, 1.63] | 0.028 |
Having an external space (terrace, garden) | 1.52 [1.09, 2.11] | 0.013 | 1.13 [0.93, 1.37] | 0.206 | 0.88 [0.74, 1.06] | 0.178 |
Type of area of residence (during lockdown) | ||||||
Rural | Ref | Ref | Ref | |||
Semi urban | 1.18 [0.75, 1.85] | 0.482 | 0.97 [0.74, 1.27] | 0.813 | 0.94 [0.72, 1.24] | 0.686 |
Urban | 1.00 [0.66, 1.53] | 0.989 | 0.73 [0.57, 0.94] | 0.016 | 1.22 [0.95, 1.57] | 0.112 |
Living with a partner during lockdown | 0.72 [0.52, 0.98] | 0.036 | 0.81 [0.68, 0.98] | 0.026 | 0.96 [0.80, 1.13] | 0.605 |
Employment during lockdown | ||||||
Teleworking | 0.91 [0.56, 1.49] | 0.718 | 0.95 [0.71, 1.26] | 0.716 | 1.52 [1.16, 1.98] | 0.002 |
Partial unemployment or receiving payroll subsidy, job loss, sick leave or disability leave | 0.98 [0.69, 1.41] | 0.929 | 1.01 [0.81, 1.25] | 0.944 | 1.76 [1.43, 2.18] | < 0.001 |
Unchanged | Ref | Ref | Ref | |||
Student | 2.19 [1.36, 3.52] | 0.001 | 1.77 [1.31, 2.39] | < 0.001 | 1.69 [1.24, 2.29] | 0.001 |
Used cannabis exclusively to self-medicate | ||||||
No | Ref | Ref | Ref | |||
Yes | 0.77 [0.47, 1.25] | 0.289 | 0.62 [0.46, 0.83] | 0.002 | 0.64 [0.48, 0.85] | 0.002 |
Home-grown cannabis | 0.19 [0.09, 0.39] | < 0.001 | 0.46 [0.34, 0.63] | < 0.001 | 0.90 [0.69, 1.18] | 0.456 |
Pre-lockdown cannabis stockpiling | 0.11 [0.08, 0.17] | < 0.001 | 0.78 [0.65, 0.93] | 0.006 | 1.38 [1.17, 1.64] | < 0.001 |
Increased tobacco use (during lockdown) | 3.07 [2.22, 4.24] | < 0.001 | 2.21 [1.76, 2.77] | < 0.001 | 1.79 [1.44, 2.24] | < 0.001 |
Increased alcohol use (during lockdown) | 2.00 [1.47, 2.71] | < 0.001 | 1.29 [1.05, 1.58] | 0.014 | 1.61 [1.34, 1.95] | < 0.001 |
Increased benzodiazepine use (during lockdown) | 2.32 [1.08, 4.99] | 0.031 | 1.57 [0.86, 2.89] | 0.144 | 1.67 [0.93, 2.99] | 0.085 |
Symptoms suggestive of COVID-19 | ||||||
No | Ref | Ref | Ref | |||
Mild symptoms without dyspnea | 0.75 [0.53, 1.06] | 0.106 | 1.04 [0.85, 1.28] | 0.683 | 1.28 [1.05, 1.55] | 0.013 |
Dyspnea | 1.26 [0.67, 2.37] | 0.471 | 1.51 [1.04, 2.21] | 0.031 | 1.88 [1.32, 2.68] | < 0.001 |
Self-reported pre-lockdown chronic pathology or anxiety/depression | ||||||
No pathology | Ref | Ref | Ref | |||
Pathology other than anxiety or depression | 0.80 [0.46, 1.39] | 0.434 | 1.10 [0.80, 1.49] | 0.558 | 1.2 [0.90, 1.60] | 0.213 |
Anxiety or depression | 1.75 [1.02, 3.01] | 0.043 | 1.53 [1.05, 2.23] | 0.025 | 1.02 [0.70, 1.47] | 0.931 |
Self-reported pre-lockdown chronic pain | 0.51 [0.33, 0.77] | 0.002 | 0.84 [0.66, 1.08] | 0.174 | 0.89 [0.71, 1.13] | 0.335 |
Depression during lockdown (HAD score > = 8) | 1.46 [1.02, 2.07] | 0.036 | 1.06 [0.83, 1.35] | 0.660 | 1.34 [1.07, 1.69] | 0.011 |
Increased pain during lockdown | 1.90 [1.31, 2.75] | 0.001 | 1.11 [0.86, 1.42] | 0.424 | 1.00 [0.79, 1.27] | 0.988 |
Sleep disorder intensification during lockdown | 3.51 [2.56, 4.82] | < 0.001 | 1.80 [1.49, 2.18] | < 0.001 | 1.35 [1.13, 1.62] | 0.001 |